These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24900373)

  • 1. Ligand-Based Site of Metabolism Prediction for Cytochrome P450 2D6.
    Rydberg P; Olsen L
    ACS Med Chem Lett; 2012 Jan; 3(1):69-73. PubMed ID: 24900373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMARTCyp: A 2D Method for Prediction of Cytochrome P450-Mediated Drug Metabolism.
    Rydberg P; Gloriam DE; Zaretzki J; Breneman C; Olsen L
    ACS Med Chem Lett; 2010 Jun; 1(3):96-100. PubMed ID: 24936230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
    Liu R; Liu J; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting drug metabolism by cytochrome P450 2C9: comparison with the 2D6 and 3A4 isoforms.
    Rydberg P; Olsen L
    ChemMedChem; 2012 Jul; 7(7):1202-9. PubMed ID: 22593031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based site of metabolism prediction for cytochrome P450 2D6.
    Moors SL; Vos AM; Cummings MD; Van Vlijmen H; Ceulemans A
    J Med Chem; 2011 Sep; 54(17):6098-105. PubMed ID: 21797232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of ionic interactions and protein dynamics to cytochrome P450 2D6 (CYP2D6) substrate and inhibitor binding.
    Wang A; Stout CD; Zhang Q; Johnson EF
    J Biol Chem; 2015 Feb; 290(8):5092-5104. PubMed ID: 25555909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMARTCyp 3.0: enhanced cytochrome P450 site-of-metabolism prediction server.
    Olsen L; Montefiori M; Tran KP; Jørgensen FS
    Bioinformatics; 2019 Sep; 35(17):3174-3175. PubMed ID: 30657882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications.
    Ford KA; Ryslik G; Sodhi J; Halladay J; Diaz D; Dambach D; Masuda M
    Drug Metab Rev; 2015 Aug; 47(3):291-319. PubMed ID: 26024250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A three-dimensional protein model for human cytochrome P450 2D6 based on the crystal structures of P450 101, P450 102, and P450 108.
    de Groot MJ; Vermeulen NP; Kramer JD; van Acker FA; Donné-Op den Kelder GM
    Chem Res Toxicol; 1996; 9(7):1079-91. PubMed ID: 8902262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical metabolism of deprenyl and its enantiomer, (S)-(+)-N,alpha-dimethyl-N-propynylphenethylamine, by cytochrome P450 2D6.
    Grace JM; Kinter MT; Macdonald TL
    Chem Res Toxicol; 1994; 7(3):286-90. PubMed ID: 8075358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of model of cytochrome P450 2D6: an in silico tool for predicting metabolism and inhibition.
    Kemp CA; Flanagan JU; van Eldik AJ; Maréchal JD; Wolf CR; Roberts GC; Paine MJ; Sutcliffe MJ
    J Med Chem; 2004 Oct; 47(22):5340-6. PubMed ID: 15481972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of atom accessibility to site of metabolism models for cytochromes P450.
    Rydberg P; Rostkowski M; Gloriam DE; Olsen L
    Mol Pharm; 2013 Apr; 10(4):1216-23. PubMed ID: 23339440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism site prediction based on xenobiotic structural formulas and PASS prediction algorithm.
    Rudik AV; Dmitriev AV; Lagunin AA; Filimonov DA; Poroikov VV
    J Chem Inf Model; 2014 Feb; 54(2):498-507. PubMed ID: 24417355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A refined substrate model for human cytochrome P450 2D6.
    de Groot MJ; Bijloo GJ; Martens BJ; van Acker FA; Vermeulen NP
    Chem Res Toxicol; 1997 Jan; 10(1):41-8. PubMed ID: 9074801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated structure- and ligand-based in silico approach to predict inhibition of cytochrome P450 2D6.
    Martiny VY; Carbonell P; Chevillard F; Moroy G; Nicot AB; Vayer P; Villoutreix BO; Miteva MA
    Bioinformatics; 2015 Dec; 31(24):3930-7. PubMed ID: 26315915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building.
    Koymans LM; Vermeulen NP; Baarslag A; Donné-Op den Kelder GM
    J Comput Aided Mol Des; 1993 Jun; 7(3):281-9. PubMed ID: 8377025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining structure- and ligand-based approaches to improve site of metabolism prediction in CYP2C9 substrates.
    Kingsley LJ; Wilson GL; Essex ME; Lill MA
    Pharm Res; 2015 Mar; 32(3):986-1001. PubMed ID: 25208877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of human cytochrome P450 2D6 with prinomastat bound.
    Wang A; Savas U; Hsu MH; Stout CD; Johnson EF
    J Biol Chem; 2012 Mar; 287(14):10834-43. PubMed ID: 22308038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism.
    Unwalla RJ; Cross JB; Salaniwal S; Shilling AD; Leung L; Kao J; Humblet C
    J Comput Aided Mol Des; 2010 Mar; 24(3):237-56. PubMed ID: 20361239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SMARTCyp cytochrome P450 metabolism prediction server.
    Rydberg P; Gloriam DE; Olsen L
    Bioinformatics; 2010 Dec; 26(23):2988-9. PubMed ID: 20947523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.